Share on facebook
Share on linkedin
Share on twitter
Share on whatsapp

Do you know “H2H Marketing Model” was formerly called “Bangalore Model”?

“H2H Marketing Model” was formerly called “Bangalore Model,” as it has been developed by one of the co-authors Prof. Dr. Uwe Sponholz on the campus of Christ University in Bangalore, India. He is a visiting professor at Christ. The model integrates current concepts in the form of a new human-oriented mindset, improved marketing process, and advanced management approaches and provides a paradigm shift for all marketing thoughts.

The H2H Marketing Model is a theoretical framework, which integrates the influencing factors of Design Thinking (DT), Service-Dominant Logic (S-DL), and Digitalization (D) into a new marketing thinking approach. Design Thinking has essentially led to understanding human centricity and thinking based on deep customer insights as a mindset and marketing as an iterative innovation process. The Service-Dominant Logic provides the theoretical foundation for human marketing by integrating many fragments and emphasizes the importance of co-creation of value in collaborative ecosystems. Digitalization has given the customer and the marketer new options and gives all participants of the marketing interaction and transaction new possibilities. Insofar digitalization serves within the H2H Marketing Model as enabler, not only as trend. The H2H Marketing Model integrates all three elements into presenting an option for a new mindset and marketing action. The three authors are Philip Kotler, Waldemar Pfoertsch and Uwe Sponholz.

First, this story starts with a “Call for Adventure”. The authors introduce the current state of marketing and ask a question to the readers: “Marketing-Quo Vadis?” “Marketing, where are you heading?” When applied to the pharmaceutical industry, it leads to the fundamental understanding that a radical change is required in the marketing model of pharma firms. And who doesn’t know what’s happening in the pharmaceutical industry today. The layman knows. The patients know. The HCPs know.

In recent years, newer concepts and ideas have emerged in marketing, which the pharma industry should consider. One of them is building Firms of Endearment. This inspiration comes from the book of the same name by Raj Sisodia, Jagdish Sheth and David Wolfe.

What pharma needs now is a sustainable model to replace the hackneyed transactional marketing model which resulted in gains either for the pharma company or the HCPs but not for whom the medicines are made – the patients.

Want to read more such exciting articles and posts?

We will send you a monthly email with a digest of most happening news and events from the sector, straight to your inbox!

Subscribe to our newsletter

Latest Posts

FREE!

Download our free eBook on out-of-the-box Pharma product marketing ideas experimented, implemented, and accomplished by world-renowned players.

What's CME World?

At CME World we bring to you the best possible elearning medical webinars and courses which will help to build your evidence-based practice. We have partnerships and associations with major Indian and international associations, this helps us to design courses which are at par with international universities.

More Articles

COVID-19 vaccine hesitancy
Mayur Kumar

COVID-19 vaccine hesitancy – A marketing strategy aid

COVID–19 vaccine hesitancy in the University of Notre Dame’s new test recommends that experts in unpredictable regions need to cooperate to beat the overall social crisis and that science can profit from utilizing immunization card advancements similar as their brands with clients do. “Market division procedures can be utilized to survive” COVID–19 vaccine hesitancy “and other wellbeing emergencies,” says Mitchell Olsen’s Journal of Consumer Affairs, Mitchell Olsen, speaker in publicizing at Mendoza College of Business, Notre Dame, with Matthew Meng of Utah State University. After the fundamental conveyance of COVID–19 vaccine hesitancy in mid–2021, some broad government assistance offices and officials acknowledged that by July fourth, mass opposition could be accomplished all through the US populace. Immunization rates started to decrease in pre–summer as individuals frantic to finish a neutralizer had so viably. Over 30% of grown–ups in the US are not yet completely immunized. The gathering led a public review of inoculation stocks to show how a pattern of market sharing can be productive. “Our survey found huge contrasts between four gatherings with decreased COVID–19 vaccine hesitancy in the nature and strength of the clarifications for their loathing for the immunizer and the reactions to which they are for the most part open,” said Olsen. “Now we discussed how affiliations, like the CDC, can select support trained professionals and purchaser specialists in future wellbeing crises.” In May, the gathering led a specialist review of 1,068 grown–ups in the United States.S. who were not inoculated or to some extent inoculated and viewed themselves as probably not going to be completely vaccinated. All individuals exhibited the significance of 16 clear explanations behind deciding not to be completely immunized. it trains them to be completely inoculated. Results, including portion profiles, were considered subsequent to partitioning respondents into one of four segments: unvaccinated refusals, unvaccinated reluctant, halfway refusals, or half delays. in the event that you can demonstrate that you will not or presumably not get the COVID19 immunizer or then again, if relevant, the back part. Read my more blogs from <a href=”https://www.cmeworld.org/author/mayurkumar/”>here</a>

Read More »

Stay in touch with us and grow your business!

© All Rights Reserved 2021